Gene · 1213
NIH grants2,119
NIH grants whose papers are about the gene, through NIH's grant-paper links.
201 to 220 of 2,119
Download this page as JSON| Grant | Title | CLTC papers | Newest fiscal year |
|---|---|---|---|
| R01CA226909 | Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC | 1 | 2025 |
| R01CA249178 | A novel therapeutic strategy to eradicate breast cancer through Hsp90 inhibition and reduced immune tolerance | 1 | 2025 |
| R01CA253860 | Integrative single cell analyses of inflammation-derived circulating hybrid cells to identify aggressive disease | 1 | 2025 |
| R01CA259001 | Targeting mechanisms of immune evasion in chemotherapy-induced senescent cells | 1 | 2025 |
| R01CA260196 | Mechanistic understanding of the lifecycle of a circulating hybrid cell | 1 | 2025 |
| R01CA264248 | Addressing biological and therapeutic gaps in rare neuroendocrine cancer with a novel organoid-based model | 1 | 2025 |
| R01CA268179 | Functional interplay between Hippo and estrogen receptor ESR1 | 1 | 2025 |
| R01CA269685 | Molecular dissecting and targeting YAP1 mediated cancer stemness and immune suppression in advanced gastric adenocarcinoma | 1 | 2025 |
| R01DC002368 | Hair Bundle Proteins | 1 | 2025 |
| R01DE027325 | Targeting the innate immune response in HNSCC | 1 | 2025 |
| R01DK048370 | Small GTP Binding Proteins in Gastrointestinal Mucosa | 1 | 2025 |
| R01DK052230 | Regulation of Intestinal Epithelial Cell Proliferation | 1 | 2025 |
| R01DK064380 | Molecular Mechanisms Regulating Epithelial Cell Apical Polarity and Ciliogenesis | 1 | 2025 |
| R01DK098145 | Control of the Renal WNK Signaling Pathway by Phase Transitions | 1 | 2025 |
| R01DK110358 | Regulation of WNK signaling by potassium and Mo25: structure, function and physiology | 1 | 2025 |
| R01DK128208 | The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial | 1 | 2025 |
| R01ES025748 | Activation of Nrf2 during embryonic development - mechanisms and consequences | 1 | 2025 |
| R01ES032036 | Genotoxic stress response and mutagenesis in normal tissues of mice deficient in homology directed repair | 1 | 2025 |
| R01ES032643 | Humanized mouse models for arsenic toxicology | 1 | 2025 |
| R01EY015625 | Hermansky-Pudlak syndrome and melanosome formation | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1213/grants?page=11